Use access key #2 to skip to page content.
$21.63 -0.08 (-0.37%)
5/12/2008 4:01 PM

Bristol Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BMY

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

590 Outperforms
74 Underperforms
 

All-Stars

135 Outperforms
13 Underperforms
 

Wall Street

17 Outperforms
1 Underperforms
 

Players bullish on BMY are also bullish on:

Players bearish on BMY are also bearish on:

Ticker Tags

Big Pharma (12), Six Sigma® (37), S&P 500 (484), New York (30), Large Cap (467), Drug Manufacturers - Major (27)
Suggest a tag

Bristol Myers Squibb Co. At A Glance

Current Price: $21.63
Last Trade Time: 5/12/2008 4:01 PM
Open: $21.90
Previous Close: $21.71
Daily Range: $21.55 - $22.00
52-Week Range: $20.05 - $32.35
Volume: 20,545,986
Market Cap: $42.98B
P/E Ratio: 21.28
Compare Our Special Broker Offers!

Stock Trends

BMY VS S&P 500 (SPY)

BMY 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for BMY

More Headlines...

Top Bull Pitch

Recs

2

Bristol Myers Squibb Co. (BMY)

Avatar jim001x (44.31) Submitted: 3/23/08 8:23 PM

At 21.46 BMY is trading close to its 52 week low with a 5.78% DY.


Last Morningstar fair value estimates were $26 and 23. S&P has a $26 target price.


BMY Was recommended by Chuck Carlson with Quadrix 1st of the year and gone down since like many others. i'll be getting p...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Bristol Myers Squibb Co. (BMY)

Avatar danblanchard (< 20) Submitted: 12/31/07 3:01 PM

More layoffs to come...

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 105 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (BMY)

Avatar Afropuffashion (45.33) Submitted: 5/12/08 3:01 PM : Underperform Start Price: $21.71 BMY Score: 1.37

Well known brands seem to be being passed up for lower quality generics as gas prices rise.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar richardrogers4 (< 20) Submitted: 5/06/08 2:04 PM : Outperform Start Price: $23.09 BMY Score: -5.74

TJC

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar atlasbooks (63.81) Submitted: 5/06/08 7:27 AM : Outperform Start Price: $23.60 BMY Score: -8.60

Cramer pick for yesterday. Says it's win-win investing. Room for growth while paying 5% dividend. They may spin off part of their nutritional division- Mead Johnson and start aquiring small pharmas to add to their pipeline. Analyst meeting is today. Stay tuned.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar jsIRA (88.93) Submitted: 5/05/08 11:45 PM : Outperform Start Price: $23.60 BMY Score: -8.60

Undervalued drug company.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BMY)

Avatar KipLargo (78.71) Submitted: 5/05/08 6:39 PM : Outperform Start Price: $23.60 BMY Score: -8.60

Considering current price, management, drugs, and potential, this is the best company to make money in for big pharma.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 105 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 18 of 18  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCowenandCo 62.72 02/01/08 Outperform NS $22.83-5.25%+1.83%-7.08
TrackJimCramer 81.00 12/17/07 Outperform 3W $27.11-20.20%-3.18%-17.03
TrackDodgeCox 93.10 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackBillNygren 54.22 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 81.11 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 86.50 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackRichPzena < 20 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackHAndW < 20 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 71.22 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 83.04 09/30/07 Outperform NS $27.82-22.25%-7.94%-14.31 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 93.79 06/25/07 Outperform NS $30.60-29.32%-6.51%-22.81
TrackCitigroup 88.76 06/13/07 Outperform NS $27.96-22.64%-6.67%-15.97
TrackDeutscheSec 89.43 04/30/07 Outperform NS $28.23-23.38%-6.13%-17.24
TrackHSBC 93.94 04/27/07 Underperform NS $27.90-22.48%-5.79%+16.69
TrackUBS 93.95 03/01/07 Outperform NS $24.87-13.02%+0.80%-13.82
TrackLehmanBros 86.05 01/12/07 Outperform NS $24.98-13.42%-1.14%-12.27
TrackPrudential 84.40 09/12/06 Outperform NS $23.16-6.62%+7.58%-14.20

Results 1 - 18 of 18  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners